Thomas Stock Selected Research

dagrocorat

1/2018

In Vitro and In Vivo Investigation of Potential for Complex CYP3A Interaction for PF-00251802 (Dagrocorat), a Novel Dissociated Agonist of the Glucocorticoid Receptor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Thomas Stock Research Topics

Disease

4	Rheumatoid Arthritis 04/2020 - 08/2017
1	Schizophrenia (Dementia Praecox) 09/2013
1	Asthma (Bronchial Asthma) 04/2007

Drug/Important Bio-Agent (IBA)

2	tofacitinibIBA 04/2020 - 01/2019
2	fosdagrocoratIBA 01/2018 - 08/2017
2	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2018 - 08/2017
1	Janus Kinase InhibitorsIBA 04/2020
1	dagrocoratIBA 01/2018
1	Antipsychotic Agents (Antipsychotics)IBA 09/2013
1	Lurasidone Hydrochloride FDA Link 09/2013
1	Dopamine (Intropin)FDA LinkGeneric 09/2013
1	LatexIBA 04/2007